16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors.
Kumamoto Health Science University
SAR analysis of adenosine diphosphate (hydroxymethyl)pyrrolidinediol inhibition of poly(ADP-ribose) glycohydrolase.
University of Kentucky
Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).
University of Arizona
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives.
University of Bologna
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale.
University of Southampton
Structural insights into the active site of poly(ADP-ribose) glycohydrolase using docking modes of 6-hydroxy-3H-xanthen-3-one derivative inhibitors.
Tokyo University of Science
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosure.
University of Manchester
Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides.
University of Manchester
X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.
Rheinische Friedrich-Wilhelms-Universit£T
[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof
Zhuhai United Laboratories Co.
NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
Chong Kun Dang Pharmaceutical
Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors
Jumbo Drug Bank
Substituted thiohydantoin derivatives as androgen receptor antagonists
Janssen Pharmaceutica
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
National Taiwan University
Oxamic acid analogues as LDH-C4-specific competitive inhibitors.
Instituto Politécnico Nacional